Carregant...
Treatment of Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) comprises a heterogeneous group with pathophysiological, genetic and clinical features. Many patients can be cured with R-CHOP therapy, which is the current standard regimen. Despite recent progress in improving patient survival, the 40% survival of DLBCL patien...
Guardat en:
| Publicat a: | J Clin Exp Hematop |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
JSLRT
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144206/ https://ncbi.nlm.nih.gov/pubmed/27980306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.56.79 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|